11 – 20 of 1444
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Comparison of CSF biomarkers in multiple sclerosis patients treated with natalizumab and rituximab
(
- Contribution to journal › Article
-
Mark
Large-scale network analysis of the cerebrospinal fluid proteome identifies molecular signatures of frontotemporal lobar degeneration
(
- Contribution to journal › Article
-
Mark
Concordance between the updated Elecsys cerebrospinal fluid immunoassays and amyloid positron emission tomography for Alzheimer's disease assessment : findings from the Apollo study
(
- Contribution to journal › Article
-
Mark
Blood Biomarkers to Detect Alzheimer Disease-Reply
(
- Contribution to journal › Letter
-
Mark
Machine learning prediction of tau-PET in Alzheimer's disease using plasma, MRI, and clinical data
(
- Contribution to journal › Article
-
Mark
Harmonizing genotype array data to understand genetic risk for brain amyloid burden in the AMYPAD PNHS Consortium
(
- Contribution to journal › Article
-
Mark
Plasma biomarker profiles in ageing : decoding neurodegeneration in vivo
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Unraveling Cognitive Decline - Integrating Biomarkers of Neurodegeneration, Vascular Pathology, and Neuroinflammation
2025) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Plasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals : implications for clinical trials
(
- Contribution to journal › Article
-
Mark
Disease stage-specific atrophy markers in Alzheimer's disease
(
- Contribution to journal › Article